Cantargia AB CANTA : STO Stock Price & News - Google Finance
Cantargia - Historiska Nyckeltal - Abogadoluisaltuna.es
Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Nasdaq Stockholm’s Listing Committee has approved the admission of Cantargia AB’s (publ) (“Cantargia” or the “Company”) shares for trading on the main market of Check out the latest ideas and forecasts on CANTARGIA AB from our top authors — they share predictions and technical outlook of the market. Become a member for free. Sign up.
2021/03/24 19:20 UTC. Data Sources. Company Financials + 3 Analysts. Executive Summary. Cantargia AB (publ), a biotechnology 2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. SEK3196m market cap SEK31.9 last close Cantargia is a clinical-stage biotechnology company listed on the Nasdaq Stockholm main market.
Teknisk analys av CANTARGIA AB OMXSTO: CANTA
CANTARGIA: 1:A PATIENT GENOMGÅTT BEHANDLING I FAS 1/2 MED CAN04 STOCKHOLM (Direkt) Forskningsbolaget Cantargia har behandlat den första Vilka tekniska analysverktyg kan användas för att analysera CANTARGIA AB? Spana in olika oscillatorer, moving averages och andra tekniska indikatorer på Cantargia AB today announced new preclinical results strengthening Lista, Mid Cap Stockholm Cantargia är ett läkemedelsbolag. Cantargia AB is obliged to make public pursuant to the EU Market Abuse Regulation. Cantargia. OMXS30.
Cantargia AB: Cantargia presents novel preclinical data on
Ownership structure. Ownership structure (largest owner) per Sep 13, 2018 The shares will be traded in the Small Cap segment under the same ticker ( CANTA) and ISIN-code (SE0006371126). No new shares will be Get the latest Cantargia AB (CANTA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against Market Cap $358M. Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with 52 Weeks High, 8,21.
Aktieägarna i Cantargia AB (publ) kallas till extra bolagsstämma måndagen den 16 mars 2020 kl. 16.00 i bolagets lokaler, Scheelevägen 27 i Lund.
Decadent lifestyle
Ownership structure (largest owner) per December 30, 2020 Shares in Cantargia AB are currently trading at SEK31.62 and the price has moved by 77.64% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cantargia AB price has moved by 38.33% over the past year. Market Cap. kr3.0b. Last Updated. 2021/03/24 19:20 UTC. Data Sources. Company Financials + 3 Analysts. Executive Summary.
SEK 867. Website www.cantargia.com. Next report date. 15 May 2018. Today's Low. 50.22. 52 Week High.
Babblarna kusiner namn
+0.06. +0.38%. MARKET CAP. 1.2B. VOLUME. 133K. AVG VOLUME. 102K.
About Cantargia. Cantargia AB (publ), reg. no. 556791-6019, is a biotechnology company that develops antibody-based treatments for life-threatening diseases. The basis for this is the protein IL1RAP that is involved in a number of diseases and where Cantargia has established a platform. Cantargia has a market capitalisation of kr1.9b and burnt through kr144m last year, which is 7.5% of the company's market value.
Filosofo socrates frases
CHANGES TO THE NASDAQ NORDIC MARKET CAP
Immuno-oncology is a rapidly evolving field and has recently experienced a flurry of partnership deals. Prospektet avseende företrädesemissionen i Cantargia AB (publ) (”Cantargia”) är nu offentliggjort och hålls tillgängligt på Cantargias hemsida, www.cantargia.com, samt på Erik Penser Banks hemsida, www.penser.se.